# T-2 Toxin Neurotoxicity: Molecular Mechanisms and Emerging Chemoprotective Strategies

**Authors:** Chunyan Xu, Gea Oliveri Conti, Shusheng Tang, Jianzhong Shen, Chongshan Dai

PMC · DOI: 10.3390/antiox15030278 · Antioxidants · 2026-02-24

## TL;DR

This review explores how T-2 toxin causes brain damage and discusses new ways to protect against its harmful effects.

## Contribution

The paper provides new insights into molecular mechanisms of T-2 toxin-induced neurotoxicity and novel chemoprotective strategies.

## Key findings

- T-2 toxin causes neurotoxicity through oxidative stress, mitochondrial dysfunction, and neuroinflammation.
- Several signaling pathways are involved in T-2 toxin-induced neurotoxicity.
- Antioxidants and natural products can reduce the harmful effects of T-2 toxin.

## Abstract

Mycotoxins can contaminate food and raw food materials and are a threat to animal and human health. T-2 toxin is the most toxic secondary metabolite mainly produced by Fusarium species among trichothecenes. T-2 toxin exposure can induce multiple toxic effects, including hepatotoxicity, nephrotoxicity, immunotoxicity, gastrointestinal toxicity, and reproductive toxicity. Recent studies have reported that T-2 toxin can cross the blood–brain barrier and trigger neurotoxicity. In this review, we summarized the neurotoxic effects caused by T-2 toxin exposure and the underlying molecular mechanisms. Additionally, effective neuroprotective agents, potential clinical applications, and future prospects are discussed. The current studies revealed that the molecular mechanisms of T-2 toxin-induced neurotoxicity involve oxidative stress, mitochondrial dysfunction, neuroinflammation, autophagy, ferroptosis and cell apoptosis. Several signaling pathways, including NFE2L2, NRF-2, PGC-1, p53, BTG2, AKNA, MAPK, Akt, mTOR, HMGB1, HIF-1, CREB, and NF-κB, are involved. Additionally, it was reported that several antioxidants, small inhibitors and nature products, such as daucosterol, betulinic acid, AHN 1-055 hydrochloride, dimethyl fumarate and minocycline supplementations, can partly ameliorate these harmful effects. This review provides valuable insights into the underlying mechanisms of T-2 toxin-induced neurotoxicity and novel effective detoxification strategies.

## Linked entities

- **Genes:** NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780], GABPA (GA binding protein transcription factor subunit alpha) [NCBI Gene 2551], PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891], TP53 (tumor protein p53) [NCBI Gene 7157], BTG2 (BTG anti-proliferation factor 2) [NCBI Gene 7832], AKNA (AT-hook transcription factor) [NCBI Gene 80709], MAPK (mitogen activated kinase-like protein) [NCBI Gene 7446652], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207], MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475], HMGB1 (high mobility group box 1) [NCBI Gene 3146], HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091], CREB1 (cAMP responsive element binding protein 1) [NCBI Gene 1385], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790]
- **Chemicals:** T-2 toxin (PubChem CID 5284461), daucosterol (PubChem CID 5742590), betulinic acid (PubChem CID 64971), AHN 1-055 hydrochloride (PubChem CID 24978533), dimethyl fumarate (PubChem CID 637568), minocycline (PubChem CID 54675783)
- **Species:** Fusarium (taxon 5506)

## Full-text entities

- **Genes:** AKNA (AT-hook transcription factor) [NCBI Gene 80709], PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891] {aka LEM6, PGC-1(alpha), PGC-1alpha, PGC-1v, PGC1, PGC1A}, CREB1 (cAMP responsive element binding protein 1) [NCBI Gene 1385] {aka CREB, CREB-1}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, HMGB1 (high mobility group box 1) [NCBI Gene 3146] {aka HMG-1, HMG1, HMG3, SBP-1}, BTG2 (BTG anti-proliferation factor 2) [NCBI Gene 7832] {aka APRO1, PC3, TIS21}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}
- **Diseases:** reproductive toxicity (MESH:D060737), mitochondrial dysfunction (MESH:D028361), gastrointestinal toxicity (MESH:D005767), Neurotoxicity (MESH:D020258), neuroinflammation (MESH:D000090862)
- **Chemicals:** daucosterol (MESH:C011015), betulinic acid (MESH:D000094062), minocycline (MESH:D008911), trichothecenes (MESH:D014255), dimethyl fumarate (MESH:D000069462), T-2 Toxin (MESH:D013605), AHN 1-055 hydrochloride (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13023939/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13023939/full.md

## References

175 references — full list in the complete paper: https://tomesphere.com/paper/PMC13023939/full.md

---
Source: https://tomesphere.com/paper/PMC13023939